[1] Burger D, Dayer JM, Palmer G, Gabay C. Is IL-1 a good therapeutic target in the treatment of arthritis? Best Pract Res Clin Rheumatol. 2006 Oct;20(5):879-96. doi: 10.1016/j.berh.2006.06.004. PMID: 16980212.
[2] Wehling P, Evans C, Wehling J, Maixner W. Effectiveness of intra-articular therapies in osteoarthritis: a literature review. Ther Adv Musculoskelet Dis. 2017 Aug;9(8):183-196. doi: 10.1177/1759720X17712695.
[3] Iqbal I, Fleischmann R. Treatment of osteoarthritis with anakinra. Curr Rheumatol Rep. 2007 Apr;9(1):31-5. doi: 10.1007/s11926-007-0019-9. PMID: 17437664.
[4] Richards MM, Maxwell JS, Weng L, Angelos MG, Golzarian J. Intra-articular treatment of knee osteoarthritis: from anti-inflammatories to products of regenerative medicine. Phys Sportsmed. 2016;44(2):101-8. doi: 10.1080/00913847.2016.1168272.
[5] Cole BJ, Karas V, Hussey K, Pilz K, Fortier LA. Hyaluronic Acid Versus Platelet-Rich Plasma: A Prospective, Double-Blind Randomized Controlled Trial Comparing Clinical Outcomes and Effects on Intra-articular Biology for the Treatment of Knee Osteoarthritis. Am J Sports Med. 2017 Feb;45(2):339-346. doi: 10.1177/0363546516665809. Epub 2016 Oct 21. Erratum in: Am J Sports Med. 2017 Apr;45(5):NP10. PMID: 28146403.
[6] Evans C. Editorial: Arthritis Gene Therapy Using Interleukin-1 Receptor Antagonist. Arthritis Rheumatol. 2018 Nov;70(11):1699-1701. doi: 10.1002/art.40675. PMID: 30035385; PMCID: PMC6203597.
[7] Nixon AJ, Grol MW, Lang HM, Ruan MZC, Stone A, Begum L, Chen Y, Dawson B, Gannon F, Plutizki S, Lee BHL, Guse K. Disease-modifying Osteoarthritis Treatment with Interleukin-1 Receptor Antagonist Gene Therapy in Small and Large Animal Models. Arthritis Rheumatol. 2018 Jul 25. doi: 10.1002/art.40668.
[8] Harrell CR, Markovic BS, Fellabaum C, Arsenijevic N, Djonov V, Volarevic V. The role of Interleukin 1 receptor antagonist in mesenchymal stem cell-based tissue repair and regeneration. Biofactors. 2020 Mar;46(2):263-275. doi: 10.1002/biof.1587. Epub 2019 Nov 22. PMID: 31755595
[9] Barreto A, Braun TR. A method to induce Interleukin-1 Receptor Antagonist Protein from autologous whole blood. Cytokine. 2016 May;81:137-41. doi: 10.1016/j.cyto.2016.03.008.
[10] Becker C, Heidersdorf S, Drewlo S, de Rodriguez SZ, Krämer J, Willburger RE. Efficacy of epidural perineural injections with autologous conditioned serum for lumbar radicular compression: an investigator-initiated, prospective, double-blind, reference-controlled study. Spine (Phila Pa 1976). 2007 Aug 1;32(17):1803-8. Erratum in: Spine. 2007 Nov 15;32(24):
[11] Frizziero A, Erika Giannotti, Francesco Oliva, Masiero S, and Nicola Maffulli. Autologous conditioned serum for the treatment of osteoarthritis and other possible applications in musculoskeletal disorders British Medical Bulletin 2013; 105: 169–184 DOI:10.1093/bmb/lds016
[12] Godek P. Use of Autologous Serum in Treatment of Lumbar Radiculopathy Pain. Pilot Study. Ortop Traumatol Rehabil. 2016 Jan-Feb;18(1):11-20. doi:10.5604/15093492.1198829.
[13] Zarringam D, Bekkers JEJ, Saris DBF. Long-term Effect of Injection Treatment for Osteoarthritis in the Knee by Orthokin Autologous Conditioned Serum. Cartilage. 2018 Apr;9(2):140-145. doi: 10.1177/1947603517743001.
[14] Barreto A, Braun TR. A new treatment for knee osteoarthritis: Clinical evidence for the efficacy of Arthrokinex™ autologous conditioned serum. J Orthop. 2016 Oct 25;14(1):4-9
[15] REGELSBERGER HS. BEDEUTUNG DER DIREKTEN INTRAVENOESEN SAUERSTOFF-INSUFFLATION (OXYVENIERUNG) FUER DIE MODERNE THERAPIE UND PROPHYLAXE [SIGNIFICANCE OF THE DIRECT INTRAVENOUS OXYGEN INSUFFLATION IN MODERN THERAPY AND PROPHYLAXIS]. Acta Neuroveg (Wien). 1964 Nov 16;27:1-74. German. doi: 10.1007/BF01226937. PMID: 14348501.
[16] Kreutzer, F.J. Intravenöse Sauerstofftherapie (IOT): Oxyvenierungstherapie nach Regelsberger in Theorie und Praxis. Von den Anfängen bis zur Gegenwart. Dr. med. H.S. Regelsberger GmbH & Co. KG (Herausgeber),
[17] Meijer H, Reinecke J, Becker C, Tholen G, Wehling P. The production of cytokines in whole blood by physico-chemical induction. Inflamm Res. 2003 Oct;52(10):404-7.